Related Experiment Videos
Elective lymph node dissection in stage I melanoma--necessary or not?
The American Surgeon
|September 1, 1985
Summary
Malignant melanoma management requires individualized therapy, not standardization. Tumor depth of invasion is the key prognostic factor, with Clark and Breslow criteria aiding assessment.
Area of Science:
- Oncology
- Dermatology
Background:
- Malignant melanoma treatment strategies are debated.
- Accurate prognostic indicators are crucial for patient management.
Purpose of the Study:
- To emphasize the importance of individualized therapy in malignant melanoma.
- To highlight depth of invasion as a primary prognostic factor.
Main Methods:
- Review of prognostic factors in malignant melanoma.
- Evaluation of established staging criteria (Clark, Breslow).
Main Results:
- Depth of invasion is the most significant prognostic determinant.
- Clark and Breslow criteria provide valuable prognostic information.
Conclusions:
- Malignant melanoma management should be tailored to individual patient characteristics.
- Standardized treatment protocols are insufficient; personalized approaches are necessary.